OpenVSafe by OpenVAERS
Search V-safe

6PV-17357-61650

2 vaccinations 5 coded responses 14 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
931 / CA
Registered
2021-04-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-15
    Registered in v-safe
  3. 2021-04-15
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-15
    Survey response — day 0, dose 2
    MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Food tastes weird.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysgeusia, Taste disorder — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Everything tastes like cardboard with lots of salt.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-22
    Survey response — day 7, dose 2
    MedDRA: Headache — Feeling: Good · Headache
    Free text: Headache wakes me up every morning between 5-6 am and goes away after a couple of hours after I get up.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-29
    Survey response — day 14, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: The first dose triggered a mild autoimmune response (rash and fatigue). It was almost gone when I got the second dose. The second dose caused the worse autoimmune flair Ive had since I was initially diagnosed two years ago.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-27
    Survey response — day 42, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Autoimmune flare up
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-07-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-10-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-04-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Pfizer-BioNTech
22021-04-15Pfizer-BioNTech

Free text

Release 7 — day 0, dose 2

2021-04-15

Systemic reaction (other): Food tastes weird.

Release 7 — days 1–6 daily, dose 2

2021-04-16

Systemic reaction (other): Everything tastes like cardboard with lots of salt.

Release 7 — day 7, dose 2

2021-04-22

Systemic reaction (other): Headache wakes me up every morning between 5-6 am and goes away after a couple of hours after I get up.

Release 8 — day 14, dose 2

2021-04-29

Symptoms: The first dose triggered a mild autoimmune response (rash and fatigue). It was almost gone when I got the second dose. The second dose caused the worse autoimmune flair Ive had since I was initially diagnosed two years ago.

Release 8 — day 42, dose 2

2021-05-27

Symptoms: Autoimmune flare up

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SRODysgeusia ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROTaste disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release